期刊
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
卷 5, 期 2, 页码 111-125出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756283X11428502
关键词
efficacy; gastrointestinal disorders; probiotic; Saccharomyces boulardii; safety
资金
- Merck
- Optimer Pharmaceuticals
Several clinical trials and experimental studies strongly suggest a place for Saccharomyces boulardii as a biotherapeutic agent for the prevention and treatment of several gastrointestinal diseases. S. boulardii mediates responses resembling the protective effects of the normal healthy gut flora. The multiple mechanisms of action of S. boulardii and its properties may explain its efficacy and beneficial effects in acute and chronic gastrointestinal diseases that have been confirmed by clinical trials. Caution should be taken in patients with risk factors for adverse events. This review discusses the evidence for efficacy and safety of S. boulardii as a probiotic for the prevention and therapy of gastrointestinal disorders in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据